Rosetta Genomics and 3 NASDAQ Top Percentage Losing Stocks

Rosetta Genomics Ltd. (NASDAQ:ROSG): Despite recently published studies that miRview mets2 are able to identify 42 tumor types with high accuracy, Rosetta Genomics continues its volatile path. Shares fell 11.75% to close at $12.32, and they have traded in a 52-week range of $1.40 to $36.45.

Complete Genomics, Inc. (NASDAQ:GNOM): After a downgrade from Outperform to Market Perform by William Blair, Complete Genomics saw a 11.88% drop to close at $2.30. They have traded in a 52-week range of $1.57 to $18.55.

magicJack VocalTec Ltd (NASDAQ:CALL): It looks like MagicJack VocalTec wishes the Wall Street Journal weren’t so vocal. After a WSJ column took a critical look at the company’s strategy of financing stock buybacks by selling options, magicJack VocalTec shares dropped 9.93% to close at $13.78. They have traded in a 52-week range of $9.49 to $28.22.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Premium Newsletters

Stock Investor Cheat Sheet

Stock Investor Cheat Sheet®

The ultimate Cheat Sheet for finding winning stock picks.
Learn More

Gold & Silver Newsletter

Gold & Silver

Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More

Commodities Premium Newsletter

Commodities Premium

There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more

ETF Investing

ETF Investing

At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business